New TB vaccine candidate takes on BCG in Mid-Stage trial
⭐️ VACCINE ⭐️
Ongoing
This study tests a new tuberculosis vaccine called MTBVAC in 164 healthy adolescents and adults, comparing it to the standard BCG vaccine. The goal is to see if MTBVAC is safe and triggers a stronger immune response. Participants include both people never exposed to TB and those …
Phase: PHASE2 • Sponsor: Bharat Biotech International Limited • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 04:12 UTC